.Pharmacolibrary.Drugs.C_CardiovascularSystem.C05B_AntivaricoseTherapy.C05BA51_HeparinoidCombinations.HeparinoidCombinations .Pharmacolibrary.Drugs.C_CardiovascularSystem.C05B_AntivaricoseTherapy.C05BA51_HeparinoidCombinations.HeparinoidCombinations| name: | HeparinoidCombinations | |
| ATC code: | C05BA51 | |
| route: | topical | |
| compartments: | 1 | |
| dosage: | 1000 | mg |
| volume of distribution: | 3.5 | L |
| clearance: | 150 | ml/min |
| other parameters in model implementation | ||
Heparinoid combinations are medicinal products containing mixtures of heparinoids, which are glycosaminoglycan-like substances with anticoagulant and anti-inflammatory effects. These combinations are often used topically for the treatment of varicose veins, superficial thrombophlebitis, bruises, and hematomas. They are available primarily as over-the-counter or prescription topical gels and creams in various countries. The systemic use of heparinoid combinations is limited, and such products are not a mainstay of anticoagulant therapy; topical use is still approved in some local markets.
No direct human pharmacokinetic data for topical heparinoid combinations (ATC code C05BA51) could be identified in peer-reviewed publications. Pharmacokinetics are presumed from limited systemic absorption studies in healthy adults after topical administration.